Intensive salvage therapy with high-dose chemotherapy for patients with advanced Hodgkin's disease in relapse or failure after initial chemotherapy: results of the Groupe d'Etudes des Lymphomes de l'Adulte H89 Trial.

Fermé, Christophe

Intensive salvage therapy with high-dose chemotherapy for patients with advanced Hodgkin's disease in relapse or failure after initial chemotherapy: results of the Groupe d'Etudes des Lymphomes de l'Adulte H89 Trial. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Jan 2002 - 467-75 p. digital

Publication Type: Clinical Trial; Journal Article; Multicenter Study

0732-183X

10.1200/JCO.2002.20.2.467 doi


Adolescent
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Carmustine--administration & dosage
Cytarabine--administration & dosage
Disease Progression
Disease-Free Survival
Dose-Response Relationship, Drug
Drug Resistance, Neoplasm
Etoposide--administration & dosage
Female
Hematopoietic Stem Cell Transplantation
Hodgkin Disease--drug therapy
Humans
Ifosfamide--administration & dosage
Male
Melphalan--administration & dosage
Middle Aged
Mitoguazone--administration & dosage
Recurrence
Salvage Therapy
Transplantation, Autologous
Vinblastine--administration & dosage
Vinorelbine